These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 4230117

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis.
    Fisher S, Fletcher AP, Alkjaersig N, Sherry S.
    J Lab Clin Med; 1967 Dec; 70(6):903-22. PubMed ID: 4228698
    [No Abstract] [Full Text] [Related]

  • 3. [Blood coagulation studies to discover the pathologically increased fibrinolytic activity of the blood that causes hemorrhage].
    Enev N.
    Vutr Boles; 1978 Dec; 17(3):41-5. PubMed ID: 150133
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inherited fibrinolytic hyperactivity.
    Self J, Matthews C.
    Arch Intern Med; 1968 Oct; 122(4):357-8. PubMed ID: 5676420
    [No Abstract] [Full Text] [Related]

  • 6. A comparative study of adult and fetal sheep fibrinogen, sulf-fibrinogen and fibrinogen degradation products.
    Loly W, Israels LG, Bishop AJ, Israels ED.
    Thromb Diath Haemorrh; 1971 Dec 31; 26(3):526-40. PubMed ID: 4259443
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Efficiency and limits of fibrinolytic system function tests].
    van de Loo J.
    Internist (Berl); 1973 Apr 31; 14(4):170-4. PubMed ID: 4577210
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test.
    Hawiger J, Niewiarowski S, Gurewich V, Thomas DP.
    J Lab Clin Med; 1970 Jan 31; 75(1):93-108. PubMed ID: 4243578
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum.
    Gormsen J, Feddersen C, Clemmensen I, Andersen RB.
    Scand J Haematol; 1972 Jan 31; 9(6):577-86. PubMed ID: 4118846
    [No Abstract] [Full Text] [Related]

  • 14. The effect of fibrinogen degradation products on plasmin activity.
    Myśliwiec M, Arnesen H, Godal HC.
    Thromb Diath Haemorrh; 1973 Jun 28; 29(3):592-7. PubMed ID: 4271546
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Relation between fibrinogen concentration, fibrin-stabilizing factor activity and fibrinolysis in hemorrhagic disease in children].
    Bebeshko VG, Donskaia SB.
    Lab Delo; 1987 Jun 28; (7):520-2. PubMed ID: 2442484
    [No Abstract] [Full Text] [Related]

  • 17. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C.
    Scand J Clin Lab Invest Suppl; 1983 Jun 28; 166():1-60. PubMed ID: 6226084
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Molecular mechanisms of blood coagulation and fibrinolysis activation].
    Worowski K.
    Postepy Hig Med Dosw; 1980 Jun 28; 34(3):189-233. PubMed ID: 6455654
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.